(HealthDay News) — For patients with primary solid tumors receiving cancer therapy, clonal hematopoiesis of indeterminate potential (CHIP) is associated with an increased risk for cardiovascular ...

Single-cell research of patients’ immune cells to guide future treatments: Dr Arivusudar John: Shardul Nautiyal, Mumbai Friday, January 16, 2026, 08:00 Hrs [IST] Single-Cell Ana ...

The Executive Secretary of the National Sugar Development Council (NSDC), Mr. Kamar Bakrin, in a recent interview with DAILY ...

An international team of scientists has analyzed the ongoing colonization by two retroviruses of the germline of koalas and ...

The presence of clonal hematopoiesis of indeterminate potential (CHIP) was linked to a 27% higher risk of heart failure (adjusted hazard ratio [aHR] 1.27). The association was mainly driven by ...

The EU project ENDOTARGET aims to improve the quality of life of people with rheumatic diseases. As part of a population cohort analysis, preliminary analyses provided initial insights into the ...

An international team of scientists analysed the ongoing colonization by two retroviruses of the germline of koalas and ...

In 2025, the NSDC signed a landmark $1 billion investment agreement with the Chinese conglomerate SINOMACH. Could you outline ...

At CES 2026, Nvidia Corp. Chief Executive Jensen Huang once again reset the economics of artificial intelligence factories.

The global companion diagnostics market is projected to grow at a robust CAGR of approximately 13% through 2031. This growth is driven by the increasing demand for personalized medicine, continuous ...

AI’s growth is driving pressure on power, water and logistics, turning physical infrastructure into a key constraint on data ...

According to MarketsandMarkets™, the Drug Discovery Technologies Market is projected to grow from about USD 30.58 billion in ...